10Hours ago
Moderna doesn’t expect a vaccine before the U.S. election, CEO says
Moderna doesn’t expect to apply for an emergency use authorization with the Food and Drug Administration for its potential Covid-19 vaccine until after the U.S. presidential election on Nov. 3, CEO Stephane Bancel told the Financial Times.
“November 25 is the time we will have enough safety data to be able to put into an EUA [emergency use authorisation] file that we would send to the FDA — assuming that the safety data is good, ie a vaccine is deemed to be safe,” Bancel told the international news publication.
The biotech firm also does not expect to have full FDA approval to distribute the vaccine to all Americans until next spring, he told the FT.
Moderna is a frontrunner in the race for a Covid-19 vaccine, next to Pfizer. Bancel’s prediction for when Moderna’s vaccine will be available may be at odds with President Donald Trump, who has said a vaccine could be ready to distribute as early as October with enough vaccine doses for all Americans by April. –Berkeley Lovelace Jr.
